Dianthus Therapeutics, Inc. Common Stock (DNTH) is a publicly traded Healthcare sector company. As of September 1, 2026, DNTH trades at $105.88 with a market cap of $5.92B and a P/E ratio of -24.84. DNTH moved -0.04% today. Year to date, DNTH is +156.27%; over the trailing twelve months it is +348.07%. Its 52-week range spans $13.37 to $117.88. Analyst consensus is strong buy with an average price target of $140.64. Rallies surfaces DNTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for DNTH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $105.88 |
| Market Cap | $5.92B |
| P/E Ratio | -24.84 |
| EPS | $-4.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $117.88 |
| 52-Week Low | $13.37 |
| Volume | 68.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.04M |
| Net Income | $-162.34M |
| Gross Margin | 0.00% |
13 analysts cover DNTH: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $140.64.